Are TEM and CTX Beta-Lactamase Genes Common among Urinary Isolates from Ain Shams Hospital Intensive Care units?

Journal Title: Immunological Disorders and Immunotherapy - Year 2021, Vol 6, Issue 2

Abstract

The extended- spectrum β-lactamase producing Gram Negative bacteria are widely spread worldwide. Productions of these enzymes cause bacterial resistance to beta-lactam antibiotics as penicillin and cephalosporins. These enzymes act by hydrolyzing these antibiotics. Many ESBL variants are known that have been classified into nine different structural and evolutionary families based upon alteration of the amino acid configuration around the enzyme active site such as TEM, SHV, CTX-M, PER, VEB, GES, BES, TLA, and OXA. Aim: To determine the distribution of ESBL (blaTEM and blaCTX-M) genes among the Gram negative isolates collected from urine samples in Intensive care units of Ain Shams University Hospitals. Materials and Methods: The study was conducted on 40 Gram negative isolates, isolated from urine samples from Intensive care units of Ain Shams University Hospitals from July 2018 till December 2018. All the isolates were subjected to conventional microbiological identification methods, Antimicrobial susceptibility testing by disc diffusion test, followed by Polymerase chain reaction for detection of blaTEM and blaCTX-M ESBL genes. Results: In this study, Phenotypic detection of ESBL among the isolates showed that 8 (20%) isolates were ESBL producers by double disc method and 32 (80%) non ESBL producers. ESBL gene (blaTEM ) was found in 15 isolates (37.5%) and ESBL gene (blaCTX-M) was found in 8 isolates (20%) and five isolates were positive for both genes. Conclusion: Traditional Phenotypic tests for ESBL production cannot detect the ESBL subtype and cannot detect those genes whose expression is masked. Therefore, the genotypic method is suggested as the method of choice for detection of ESBL-producing strains among gram negative bacteria. The distribution of blaTEM was (37.5%) and blaCTX-M was (20%) and five isolates were positive for both gene.

Authors and Affiliations

Nadia M. Elsheshtawy, Shimaa A. Abdel Salam

Keywords

Related Articles

Th1 Cytokine Profile Associated of Severe Malaria Resistance In Endemic Areas

Introduction: Malaria, a disease caused by protozoan parasites of the genus Plasmodium. Despite the premunition, some adults still experience the severe form of malaria. The study hereby aims to investigate the involveme...

Unique COVID/Anti-Spike Protein Immune Responses in Two Elderly Patients without COVID-19 Vaccination

Published reports continue to emerge regarding different health outcomes in patients immunized and not immunized against the SARS-CoV-2 antigen (i.e., spike protein) that were infected with the virus. Because of the vast...

P-Selectin is a Key Molecule Underlying the Pathophysiology of AspirinExacerbated Respiratory Disease

Recently, the evidence for platelet association with allergic diseases has been established by many researches. Activated platelets contribute to airway hyper reactivity, bronchoconstriction, airway inflammation and airw...

Targeting Immune-Evasion Mechanisms as a Possible New Approach in the Fight against Tuberculosis

The emergence of multidrug resistant Mycobacterium tuberculosis (Mtb) strains, the difficulties in the development of new safe therapies or the production of a protective vaccine against tuberculosis make the study of th...

Curcumol Targets Gls1 to Regulate Glutamine Metabolism and Induce Senescence of Hepatic Stellate Cells to Exert Anti-Hepatic Fibrosis Mechanism

Objective: Curcuma has long been used as a Chinese herbal medicine for the treatment of chronic liver disease, and curcumol is its main active ingredient. This study explores the molecular mechanism of curcumol regulatin...

Download PDF file
  • EP ID EP743045
  • DOI -
  • Views 55
  • Downloads 0

How To Cite

Nadia M. Elsheshtawy, Shimaa A. Abdel Salam (2021). Are TEM and CTX Beta-Lactamase Genes Common among Urinary Isolates from Ain Shams Hospital Intensive Care units?. Immunological Disorders and Immunotherapy, 6(2), -. https://europub.co.uk/articles/-A-743045